Shopping Cart
Remove All
Your shopping cart is currently empty
Ubamatamab
(Synonyms: REGN4018) Copy Product Info
🥰Excellent
Synonyms: REGN4018
Catalog No. T76967 Copy Product Info
🥰Excellent
Ubamatamab represents a highly specialized bispecific T-cell engaging antibody specifically engineered to bridge the structural gap between MUC16-expressing malignant ovarian cancer cells and cytotoxic T-lymphocytes by maintaining stable engagement with the CD3 receptor complex to evaluate the induction of tumor-specific immune responses across various preclinical experimental models in specialized oncology research environments.
Ubamatamab
Cas No. 2305629-50-7
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $479 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:>95% (SDS-PAGE); 98.42% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Ubamatamab represents a highly specialized bispecific T-cell engaging antibody specifically engineered to bridge the structural gap between MUC16-expressing malignant ovarian cancer cells and cytotoxic T-lymphocytes by maintaining stable engagement with the CD3 receptor complex to evaluate the induction of tumor-specific immune responses across various preclinical experimental models in specialized oncology research environments. |
| In vitro | In T-cell engagement assays using ovarian cancer cell lines, Ubamatamab (REGN4018) facilitated cytolytic synapse formation with MUC16-expressing tumor cells, leading to target cell lysis [1]. |
| In vivo | In MUC16-expressing human tumor xenograft models, systemic administration of Ubamatamab (REGN4018) resulted in significant tumor regression and durable antitumor immunity [1]. |
| Synonyms | REGN4018 |
| Reactivity | Human |
| Verified Activity | OVCAR-3 cells at 1×10^5 cells/well can bind Ubamatamab. The EC50 is 0.421 nM.
huCD3e-Jurkat cells at 1×10^5 cells/well can bind Ubamatamab. The EC50 is 15.06 nM.  , |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD3E & MUC16 |
| Molecular Weight | 144.64 kDa |
| Cas No. | 2305629-50-7 |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | Store at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: Ubamatamab in vivo | Ubamatamab in vitro | Ubamatamab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.